Edition:
United States

Tetraphase Pharmaceuticals Inc (TTPH.OQ)

TTPH.OQ on NASDAQ Stock Exchange Global Select Market

2.32USD
19 Oct 2018
Change (% chg)

$-0.12 (-4.92%)
Prev Close
$2.44
Open
$2.44
Day's High
$2.47
Day's Low
$2.31
Volume
144,404
Avg. Vol
192,860
52-wk High
$6.97
52-wk Low
$2.06

Select another date:

Mon, Aug 27 2018

FDA approves Tetraphase Pharma's antibiotic

Tetraphase Pharmaceuticals Inc said on Monday U.S. health regulators approved its drug to treat complicated intra-abdominal infections, providing a new option to combat the growing threat from treatment-resistant bacteria.

UPDATE 1-U.S. FDA approves Tetraphase Pharma's antibiotic

Aug 27 Tetraphase Pharmaceuticals Inc said on Monday U.S. health regulators approved its drug to treat complicated intra-abdominal infections, providing a new option to combat the growing threat from treatment-resistant bacteria.

U.S. FDA approves Tetraphase Pharma's antibiotic

Aug 27 The U.S. Food and Drug Administration on Monday approved Tetraphase Pharmaceuticals Inc's antibiotic for complicated intra-abdominal infections, providing a new option to combat the growing problem of treatment-resistant bacteria.

Select another date: